| Dr Ed Tojino Corpus Jr, MD | |
|
317 Brewster St E, Harvey, ND 58341-1653 | |
| (701) 324-4134 | |
| (701) 324-4205 |
| Full Name | Dr Ed Tojino Corpus Jr |
|---|---|
| Gender | Male |
| Speciality | Surgery |
| Location | 317 Brewster St E, Harvey, North Dakota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144333709 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 5394 (North Dakota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ed Tojino Corpus Jr, MD 317 Brewster St E, Harvey, ND 58341-1653 Ph: (701) 324-4134 | Dr Ed Tojino Corpus Jr, MD 317 Brewster St E, Harvey, ND 58341-1653 Ph: (701) 324-4134 |
News Archive
Global Research Services, LLC (GRS), an international cardiovascular clinical research organization (CRO) serving pharmaceutical, biotech and medical device companies with comprehensive clinical trial management services, announced today that Benoît Martin, a seasoned executive with more than a decade of leading international CRO business units, has been named as the European General Manager and Executive Vice President of Global Development.
A heathy diet is linked to better reading skills in the first three school years, shows a recent study from Finland. Published in the European Journal of Nutrition, the study constitutes part of the Physical Activity and Nutrition in Children Study conducted at the University of Eastern Finland and the First Steps Study conducted at the University of Jyväskylä.
With the help of effective drug therapies, HIV patients are living longer, healthier lives. Now, researchers want to improve these drug therapies and develop alternative preventative strategies, such as vaginal gels and creams that contain the same or related compounds used in treatments for people infected with HIV.
Neuroscientists at SRI International have found that a form of baclofen, a drug used to treat muscle spasticity, works better at treating narcolepsy than the best drug currently available when tested in mice.
Alere Inc., a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, announced today that on September 29, 2011, it has purchased an additional 5,443,771 shares of Axis-Shield stock, bringing its total current ownership position to 10,990,468 shares, or approximately 21.98%, of Axis-Shield's issued and outstanding ordinary share capital.
› Verified 8 days ago